Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cyproterone acetate + estradiol
- Development stage
- Unknown
- Lead developer
- Bayer
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This drug is a hormonal combination therapy consisting of **cyproterone acetate** (50 mg) and **natural estradiol** (2 mg), currently being studied by **University Hospital, Lille** for the treatment of **polycystic ovary syndrome (PCOS)**. Cyproterone acetate is a synthetic steroidal compound with potent antiandrogenic and progestogenic activity, while estradiol is a naturally occurring estrogen. The combination is designed to suppress the hypothalamic-pituitary-gonadal (HPG) axis, thereby reducing ovarian androgen production and blocking the effects of circulating androgens at the receptor level. In the specific clinical trial (NCT03738423), this regimen is used to investigate microstructural and metabolic changes in the hypothalamus of women with PCOS using high-resolution magnetic resonance imaging (MRI) and proton magnetic resonance spectroscopy.
- Other names
- cyproterone acetate and estradiolCPA + E2
02
Targets
PR (Progesterone receptor)GR (Glucocorticoid receptor)AR (Adrenergic receptors)MR (Mineralocorticoid receptor)ER (Estrogen receptor)
Beyond the preview
Go deeper on cyproterone acetate + estradiol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cyproterone acetate + estradiol.